Celsius (CELH) to Release Earnings on Thursday

Celsius (NASDAQ:CELH) is anticipated to announce its Q4 2025 results before the market opens on Thursday, February 19th. Analysts expect Celsius to post earnings of $0.19 per share and revenue of $638.1690 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, March 4, 2026 at 9:30 AM ET.

Celsius Price Performance

Shares of CELH stock opened at $44.35 on Thursday. The company has a current ratio of 1.89, a quick ratio of 1.61 and a debt-to-equity ratio of 0.72. The stock has a market capitalization of $11.43 billion, a price-to-earnings ratio of 443.50, a P/E/G ratio of 0.76 and a beta of 0.90. The stock has a fifty day simple moving average of $48.56 and a two-hundred day simple moving average of $52.11. Celsius has a twelve month low of $21.10 and a twelve month high of $66.74.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CELH. KeyCorp started coverage on Celsius in a report on Tuesday, December 16th. They set a “sector weight” rating for the company. Bank of America reduced their target price on shares of Celsius from $50.00 to $45.00 and set an “underperform” rating for the company in a report on Friday, December 19th. Royal Bank Of Canada restated an “outperform” rating on shares of Celsius in a research note on Thursday, November 6th. Roth Mkm reiterated a “buy” rating on shares of Celsius in a research report on Monday. Finally, UBS Group restated a “buy” rating and issued a $70.00 price objective (up previously from $65.00) on shares of Celsius in a report on Wednesday, January 14th. Eighteen research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $66.33.

Hedge Funds Weigh In On Celsius

Large investors have recently modified their holdings of the stock. Ameriprise Financial Inc. lifted its stake in Celsius by 20.9% during the second quarter. Ameriprise Financial Inc. now owns 2,470,088 shares of the company’s stock worth $114,587,000 after purchasing an additional 426,623 shares during the last quarter. Invesco Ltd. grew its position in shares of Celsius by 13.0% during the 3rd quarter. Invesco Ltd. now owns 1,801,922 shares of the company’s stock valued at $103,592,000 after buying an additional 207,824 shares during the last quarter. Northern Trust Corp raised its stake in Celsius by 2.2% during the third quarter. Northern Trust Corp now owns 1,420,607 shares of the company’s stock worth $81,671,000 after acquiring an additional 30,129 shares during the period. Scopus Asset Management L.P. bought a new position in Celsius in the second quarter worth about $59,382,000. Finally, AQR Capital Management LLC grew its holdings in shares of Celsius by 43.5% during the third quarter. AQR Capital Management LLC now owns 1,155,422 shares of the company’s stock valued at $66,425,000 after purchasing an additional 350,518 shares during the last quarter. Institutional investors own 60.95% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc is an American beverage company known for its line of fitness and energy drinks formulated to support active lifestyles. The company’s flagship product, the Celsius® brand, features beverages enhanced with ingredients such as green tea extract, guarana seed extract and essential vitamins, positioned as a functional alternative to traditional energy drinks. These products are designed to deliver a blend of ingredients that support metabolism and sustained energy without high sugar content or artificial preservatives.

In addition to its core carbonated drink portfolio, Celsius has expanded its offerings to include powder mixes and non-carbonated ready-to-drink variants, catering to consumer preferences around taste, convenience and nutritional needs.